Early Intervention With Atorvastatin Modulates Th1/Th2 Imbalance in Patients With Acute Coronary Syndrome: From Bedside to Bench
- 11 May 2004
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (18), e213
- https://doi.org/10.1161/01.cir.0000127616.70152.5d
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 DevelopmentCirculation Research, 2003
- High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL StudyCirculation, 2003
- Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectorisThe American Journal of Cardiology, 2003
- Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular CellsCirculation, 2002
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Reduction in Interleukin-2-Producing Cells but not Th1 to Th2 Shift in Moderate and Advanced Stages of Human Immunodeficiency Virus Type-1-Infection: Direct Analysis of Intracellular Cytokine Concentrations in CD4+ CD8- T CellsScandinavian Journal of Immunology, 1999
- Molecular Bases of the Acute Coronary SyndromesCirculation, 1995